Followers | 251 |
Posts | 50098 |
Boards Moderated | 46 |
Alias Born | 08/29/2007 |
Friday, December 08, 2023 9:07:58 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent INTS News
- Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors • PR Newswire (US) • 05/15/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:00:37 PM
- Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug Candidate • PR Newswire (US) • 05/10/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:13:55 PM
- Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/09/2024 08:08:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:01:27 PM
- Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 • PR Newswire (US) • 04/02/2024 12:01:00 PM
- Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares • GlobeNewswire Inc. • 03/26/2024 12:01:13 PM
- Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 03/14/2024 08:09:00 PM
- Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024 • PR Newswire (US) • 03/14/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:06:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:05:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:02:37 PM
- Intensity Therapeutics to Present at the 2024 BIO CEO & Investor Conference • PR Newswire (US) • 02/21/2024 01:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:15:27 PM
- Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program • PR Newswire (US) • 01/03/2024 01:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 01:02:25 PM
- Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer • PR Newswire (US) • 12/12/2023 01:01:00 PM
- Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer in a Podium Poster Spotlight Discussion at the 2023 SABCS • PR Newswire (US) • 12/08/2023 01:30:00 PM
- Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium • PR Newswire (US) • 12/01/2023 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:10:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:02:25 PM
- Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 11/13/2023 01:01:00 PM
- Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023 • PR Newswire (US) • 11/02/2023 11:01:00 AM
- Intensity Therapeutics Receives Orphan Drug Designation for the three key ingredients in INT230-6 for the Treatment of Soft Tissue Sarcoma • PR Newswire (US) • 09/07/2023 12:01:00 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONG • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM